Influenza A virus PA protein antibody

An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization.

Targeting influenza A virus by splicing inhibitor herboxidiene reveals the importance of subtype-specific signatures around splice sites.

SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus.

Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense. Fernbach S et al., 2022 Mar 22, Cell Rep

Multi-Omics-Guided Discovery of Omicsynins Produced by Streptomyces sp. 1647: Pseudo-Tetrapeptides Active Against Influenza A Viruses and Coronavirus HCoV-229E. Sun H et al., 2022 Sep, Engineering (Beijing)

p21 restricts influenza A virus by perturbing the viral polymerase complex and upregulating type I interferon signaling. Ma C et al., 2022 Feb, PLoS Pathog

Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity. Bdeir N et al., 2021 Oct 14, Sci Rep

MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes. Liu X et al., 2021 Jul 20, Nat Commun

8-O-(E-p-methoxycinnamoyl)harpagide Inhibits Influenza A Virus Infection by Suppressing Intracellular Calcium. Kwon EB et al., 2021 Feb 15, Molecules

Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly. Gong W et al., 2021 Mar 3, J Virol